Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial
基于麻疹载体的SARS-CoV-2候选疫苗V591在成人中的安全性和免疫原性:一项1/2期随机、双盲、安慰剂对照、剂量范围试验的结果
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2021.103811
Vanhoutte, Frédéric; Liu, Wen; Wiedmann, Richard T; Haspeslagh, Liesbeth; Cao, Xin; Boundy, Keith; Aliprantis, Antonios; Davila, Michelle; Hartzel, Jonathan; Li, Jianing; McGuire, Mac; Ramsauer, Katrin; Tomberger, Yvonne; Tschismarov, Roland; Brown, Deborah D; Xu, Weifeng; Sachs, Jeffrey R; Russell, Kevin; Stoch, S Aubrey; Lai, Eseng